The Toronto-Dominion Bank Acquires 5.5% Stake in Immatics N.V. (IMTX)

2026-05-15SEC Filing SCHEDULE 13G (0000947263-26-000045)

The Toronto-Dominion Bank has filed a Schedule 13G with the SEC, reporting a new 5.5% ownership stake in Immatics N.V. (IMTX). As of the event date on March 31, 2026, the bank beneficially owns 7,436,342 ordinary shares. The filing indicates that Toronto-Dominion Bank holds sole voting and dispositive power over the entirety of these shares. This position represents a significant increase from a previous ownership level of 0.0%, signaling a substantial new investment by the Canadian financial institution. The securities were acquired in the ordinary course of business and are not held for the purpose of influencing or changing the control of the issuer. The filing was signed on May 15, 2026, by Christina Petrou, Executive Vice President & Chief Operating Officer. Immatics N.V., a biotechnology company based in Germany, is the issuer of the ordinary shares. This transaction highlights a notable institutional entry into the company's equity structure.

Ticker mentioned:IMTXInstitution mentioned:TORONTO DOMINION BANK
Related industry:Biotechnology